TCELLVAX
Regen BioPharma, Inc
Mark For: TCELLVAX™ trademark registration is intended to cover the category of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86899728 |
| Mark Literal Elements | TCELLVAX |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED 2016-12-19 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Marc Baumgartner |
| Law Office Assigned | L20 |
| Employee Name | SMIGA, HOWARD |
Timeline
| 2016-02-05 | Application Filed |
| 2016-11-25 | Abandon |
| 2016-12-19 | Location: TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED |
| 2016-12-19 | Status: Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this fi |
| 2016-12-19 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  Regen BioPharma, Inc |
| Address | 4700 SPRING ST. La Mesa, CALIFORNIA UNITED STATES 91942 |
| Legal Entity Type | Corporation |
| Legal Entity State | NEVADA |
Documents
 Drawing | 2016-02-05 | |
| TEAS Plus New Application | 2016-02-05 | |
| Notice of Pseudo Mark | 2016-02-12 | |
| Notation to File | 2016-05-22 | |
| XSearch Search Summary | 2016-05-22 | |
| Notation to File | 2016-05-23 | |
| Offc Action Outgoing | 2016-05-23 | |
| XSearch Search Summary | 2016-05-23 | |
| Change of Address | 2016-07-06 | |
| Notice of Abandonment | 2016-12-19 |
Attorney of Record
Good, Services, and Codes
(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical products for the prevention and treatment of cancer
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical products for the prevention and treatment of cancer |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2016-12-19 | |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2016-12-19 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2016-07-06 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-05-23 | 6325 |
| NON-FINAL ACTION WRITTEN | 2016-05-23 | 73731 |
| NON-FINAL ACTION E-MAILED | 2016-05-23 | 6325 |
| ASSIGNED TO EXAMINER | 2016-05-22 | 73731 |
| NOTICE OF PSEUDO MARK E-MAILED | 2016-02-12 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-02-11 | |
| NEW APPLICATION ENTERED IN TRAM | 2016-02-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 